344 related articles for article (PubMed ID: 16283147)
61. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations.
Lee JS; John EM; McGuire V; Felberg A; Ostrow KL; DiCioccio RA; Li FP; Miron A; West DW; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):359-63. PubMed ID: 16492929
[TBL] [Abstract][Full Text] [Related]
62. Prophylactic mastectomy for BRCA mutation carriers after ovarian cancer treatment: is it beneficial?
Kotsopoulos J; Narod SA
Expert Rev Anticancer Ther; 2018 Mar; 18(3):199-200. PubMed ID: 29308680
[No Abstract] [Full Text] [Related]
63. Hereditary gynecologic cancers: differential diagnosis, surveillance, management and surgical prophylaxis.
Lu KH
Fam Cancer; 2008; 7(1):53-8. PubMed ID: 17636427
[TBL] [Abstract][Full Text] [Related]
64. The RAD51C exonic splice-site mutations c.404G>C and c.404G>T are associated with familial breast and ovarian cancer.
Neidhardt G; Becker A; Hauke J; Horváth J; Bogdanova Markov N; Heilmann-Heimbach S; Hellebrand H; Thiele H; Altmüller J; Nürnberg P; Meindl A; Rhiem K; Blümcke B; Wappenschmidt B; Schmutzler RK; Hahnen E
Eur J Cancer Prev; 2017 Mar; 26(2):165-169. PubMed ID: 27622768
[TBL] [Abstract][Full Text] [Related]
65. Breast cancer and ovarian cancer genetics: an update.
Edlich RF; Cross CL; Wack CA; Chase ME; Lin KY; Long WB
J Environ Pathol Toxicol Oncol; 2008; 27(4):245-56. PubMed ID: 19105530
[TBL] [Abstract][Full Text] [Related]
66. Large-scale meta-analysis of mutations identified in panels of breast/ovarian cancer-related genes - Providing evidence of cancer predisposition genes.
Suszynska M; Klonowska K; Jasinska AJ; Kozlowski P
Gynecol Oncol; 2019 May; 153(2):452-462. PubMed ID: 30733081
[TBL] [Abstract][Full Text] [Related]
67. Hereditary breast and ovarian cancer: what the primary care physician should know.
Khoury-Collado F; Bombard AT
Obstet Gynecol Surv; 2004 Jul; 59(7):537-42. PubMed ID: 15199272
[TBL] [Abstract][Full Text] [Related]
68. [Problems raised by the gynaecologic management of women with BRCA 1 & 2 mutations.Gynécol Obstét Fertil 2003;31:370-377].
Stoppa-Lyonnet D
Gynecol Obstet Fertil; 2003 Oct; 31(10):888-9; author reply 889. PubMed ID: 14642951
[No Abstract] [Full Text] [Related]
69. [Hereditary breast cancer].
Schlehe B; Schmutzler R
Chirurg; 2008 Nov; 79(11):1047-54. PubMed ID: 18854964
[TBL] [Abstract][Full Text] [Related]
70. No. 366-Gynaecologic Management of Hereditary Breast and Ovarian Cancer.
Jacobson M; Bernardini M; Sobel ML; Kim RH; McCuaig J; Allen L
J Obstet Gynaecol Can; 2018 Nov; 40(11):1497-1510. PubMed ID: 30473125
[TBL] [Abstract][Full Text] [Related]
71. A regional population-based hereditary breast cancer screening tool in Italy: First 5-year results.
Cortesi L; Baldassarri B; Ferretti S; Razzaboni E; Bella M; Bucchi L; Canuti D; De Iaco P; De Santis G; Falcini F; Galli V; Godino L; Leoni M; Perrone AM; Pignatti M; Saguatti G; Santini D; Sassoli de'Bianchi P; Sebastiani F; Taffurelli M; Tazzioli G; Turchetti D; Zamagni C; Naldoni C
Cancer Med; 2020 Apr; 9(7):2579-2589. PubMed ID: 32045136
[TBL] [Abstract][Full Text] [Related]
72. Educational review: role of the surgeon in hereditary breast cancer.
Newman LA; Kuerer HM; Hunt KK; Vlastos G; Ames FC; Ross MI; Singletary SE
Ann Surg Oncol; 2001 May; 8(4):368-78. PubMed ID: 11352312
[TBL] [Abstract][Full Text] [Related]
73. The
Moghadasi S; Meeks HD; Vreeswijk MP; Janssen LA; Borg Å; Ehrencrona H; Paulsson-Karlsson Y; Wappenschmidt B; Engel C; Gehrig A; Arnold N; Hansen TVO; Thomassen M; Jensen UB; Kruse TA; Ejlertsen B; Gerdes AM; Pedersen IS; Caputo SM; Couch F; Hallberg EJ; van den Ouweland AM; Collée MJ; Teugels E; Adank MA; van der Luijt RB; Mensenkamp AR; Oosterwijk JC; Blok MJ; Janin N; Claes KB; Tucker K; Viassolo V; Toland AE; Eccles DE; Devilee P; Van Asperen CJ; Spurdle AB; Goldgar DE; García EG
J Med Genet; 2018 Jan; 55(1):15-20. PubMed ID: 28490613
[TBL] [Abstract][Full Text] [Related]
74. Hereditary ovarian and breast cancer: what have we learned?
Lynch HT; Snyder C; Casey MJ
Ann Oncol; 2013 Nov; 24 Suppl 8():viii83-viii95. PubMed ID: 24131978
[TBL] [Abstract][Full Text] [Related]
75. Overview of hereditary breast and ovarian cancer (HBOC) guidelines across Europe.
Marmolejo DH; Wong MYZ; Bajalica-Lagercrantz S; Tischkowitz M; Balmaña J;
Eur J Med Genet; 2021 Dec; 64(12):104350. PubMed ID: 34606975
[TBL] [Abstract][Full Text] [Related]
76. Effect of BRCA2 mutation on familial breast cancer survival: A systematic review and meta-analysis.
Shao J; Yang J; Wang JN; Qiao L; Fan W; Gao QL; Feng YJ
J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):629-634. PubMed ID: 26489613
[TBL] [Abstract][Full Text] [Related]
77. Black and Minority Ethnic women's decision-making for risk reduction strategies after BRCA testing: Use of context and knowledge.
Machirori M; Patch C; Metcalfe A
Eur J Med Genet; 2019 May; 62(5):376-384. PubMed ID: 30550831
[TBL] [Abstract][Full Text] [Related]
78. SEOM clinical guidelines in hereditary breast and ovarian cancer (2019).
González-Santiago S; Ramón Y Cajal T; Aguirre E; Alés-Martínez JE; Andrés R; Balmaña J; Graña B; Herrero A; Llort G; González-Del-Alba A;
Clin Transl Oncol; 2020 Feb; 22(2):193-200. PubMed ID: 31889241
[TBL] [Abstract][Full Text] [Related]
79. Mutational profile of hereditary breast and ovarian cancer - Establishing genetic testing guidelines in a developing country.
Krivokuca A; Mihajlovic M; Susnjar S; Spasojevic IB; Minic I; Popovic L; Brankovic-Magic M
Curr Probl Cancer; 2022 Feb; 46(1):100767. PubMed ID: 34284872
[TBL] [Abstract][Full Text] [Related]
80. Recommendations for medical management of hereditary breast and ovarian cancer: the French National Ad Hoc Committee.
Eisinger F; Alby N; Bremond A; Dauplat J; Espié M; Janiaud P; Kuttenn F; Lebrun JP; Lefranc JP; Pierret J; Sobol H; Stoppa-Lyonnet D; Thouvenin D; Tristant H; Feingold J
Ann Oncol; 1998 Sep; 9(9):939-50. PubMed ID: 9818066
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
